We took a second look at our IPO dossiers, and I sent a video update on our revolutionary pharma holding.

You must subscribe to Cannabis IPO Insider to view this content.

To learn more and access special member pricing contact our VIP team at 1-866-298-7257. 

Sign In

Enter your details below.